Siemens launches Optimize MyProgramming/3D Scanner for improved CNC programming efficiency

Roland Busch President and Chief Executive Officer at Siemens Siemens
Roland Busch President and Chief Executive Officer at Siemens - Siemens
0Comments

With the introduction of Optimize MyProgramming/3D Scanner, users can now create and optimize CNC programs directly on the controller. The 3D Scanner provides tailored suggestions for manufacturing strategies based on geometric features, which helps to reduce both time and costs while improving parameterization of machining cycles. This process aims to prevent programming errors and maintain consistent production quality.

The software was piloted in collaboration with machine manufacturer DMG MORI, where it demonstrated its ability to enhance manufacturing processes and integrate into existing systems. According to the release, “Optimize MyProgramming /3D Scanner is integrated as a standard option in all DMG MORI machines equipped with Sinumerik One. The software will be available for purchase starting in autumn.”

The product is available as a perpetual license for use with real machine tools and as an option for digital twins through Run MyVirtual Machine. Comprehensive consulting and implementation support are provided by experienced service providers to ensure smooth integration into modern production environments.

“With Optimize MyProgramming/3D Scanner, Siemens reinforces its commitment to shaping the future of the manufacturing industry with advanced technologies and efficient solutions. The software sets new standards in CNC programming and enables manufacturing companies to make higher-quality products with more efficient production processes,” according to the company.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.